PetMed Express Inc. (PETS) Shares Tick Up after Upgrade at Zacks Investment Research

Zacks Investment Research (PetMed Express Inc.: NASDAQ) shares rose in value Wednesday Dec 28 with lighter trade volume than normal after a number of analysts weighed in on the investing value of the stock with a upgraded rating.

Meanwhile, U.S. stocks were little changed on Wednesday, as investors found few reasons to keep pushing shares higher towards the 20,000 mark.

The Dow Jones Industrial Average DJIA, -0.11% rose 3.1 points to 19,949, essentially unchanged on the day. The S&P 500 SPX, -0.39% lost 3 points, or 0.1%, to 2,266 while the Nasdaq Composite Index COMP, -0.59% slipped 6.4 points, or 0.1%, to 5,482.

Analysts at Zacks Investment Research upgraded shares of Zacks Investment Research (PetMed Express Inc.: NASDAQ) from Sell to Hold today. The company currently has a rating of Hold on the shares. As a means of comparison, a number of other analysts have spoken on the stock recently, and PetMed Express Inc. has secured a consensus one-year price target of $16.00, a decrease compared to the opening price of $23.13, a difference of 6.91 percent. PetMed Express Inc. stock has a 52-week high of $23.78. Stock prices often move to the upside on recommendations and new price targets of professional brokerage firms.

Zacks Investment Research (PetMed Express Inc.: NASDAQ) shares last traded at $23.15, an increase of $0.10 or 0.43% from the previous closing price. Opening at $23.13, they ranged from $23.09 and $23.20 throughout the day.

Zacks Investment Research (PetMed Express Inc.: NASDAQ) now has a market cap of 468.86M.

Zacks Investment Research (PetMed Express Inc.: NASDAQ) Average Daily Trading Volume

6,522 shares traded hands yesterday, below the average, out of a total float 17,811,000. Momentum traders often use swings in trading volume to determine heavy volume growth or circulation by institutional investors, so trading volume is likely to increase in the next few days.

However, a single day of heavy buy side trading is not enough to affirm a trend. As such, market traders will continue to watch for institutional sponsorship as a cue that financial institutions are moving forward.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These instituitional investors have teams of analysts that investigate thousands of stocks, so it is good corroboration to see them buying a stock you’re considering.

Zacks Investment Research (PetMed Express Inc.: NASDAQ) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By identifying trends, moving averages allow investors to make those trends work in their favor and increase the number of winning trades.

Trades for Zacks Investment Research (PetMed Express Inc.: NASDAQ) have ranged from $15.73 – 23.78, and the stock now has a 50-day MA of $22.22 and 200-day MA of $20.49. Today’s last price is 2.65%% below the 52 week high of $23.78.

Indeed, earnings growth is among the most critical things to look at in regards to stock investing and, accordingly, investors watch for companies that have been successful at growing their earnings at least 25% or more over the past 3 years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *